Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EYA3 | Q99504 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.32 |
| ▸ | PREP | P48147 | 1/20 | 0.32 |
| ▸ | CELA1 | Q9UNI1 | 1/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24103740 | 0.88 | CYP2C19 (0.32) | EYA3KDRPREPCELA1 | |
| SCHEMBL24266787 | 0.87 | EYA3 (0.36) | EYA3KDRPREPCELA1SLC22A12 | |
| SCHEMBL25816065 | 0.82 | CYP2C19 (0.30) | — | |
| SCHEMBL22680601 | 0.79 | EYA3 (0.39) | EYA3KDRPREPCELA1 | |
| SCHEMBL24266348 | 0.78 | KDR (0.32) | EYA3KDRPREPCELA1THRA | |
| SCHEMBL26211199 | 0.76 | CYP2C19 (0.41) | EYA3SLC22A12THRATHRB | |
| SCHEMBL26211957 | 0.74 | EYA3 (0.42) | EYA3SLC22A12THRB | |
| SCHEMBL24267353 | 0.74 | ALDH1A1 (0.39) | EYA3SLC22A12 | |
| SCHEMBL22680479 | 0.74 | TTR (0.43) | EYA3SLC22A12THRB | |
| SCHEMBL24103744 | 0.73 | EYA3 (0.42) | EYA3SLC22A12THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023098872-A1 | CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA | ARTHROSI THERAPEUTICS, INC. (US) | 2023-06-08 | — | — | WO | disclosed |